Wire flash
Jindan Technology: PLA Project Still in Trial Run, No Orders Received
Editorial responsibility
- No named human review is recorded for this page.
- Source reporting is collected, normalized, translated or condensed automatically when needed.
- Automatically published source-backed update
Jindan Technology (300829.SZ) saw its stock price hit the 20% daily limit up, after three consecutive trading days (September 17, 18, and 21, 2026) saw cumulative closing price gains exceeding 30%, triggering an abnormal stock trading volatility announcement. The company stated that its main business remains the production and sale of lactic acid and its series products. Its annual 75,000-ton polylactic acid biodegradable new material project is still in the trial operation phase, with both project commissioning and capacity release timelines subject to uncertainty. Crucially, the company has not received any orders related to polylactic acid. The announcement urged investors to invest rationally and be aware of investment risks.
Source report
Shanghai, September 21 — Jindan Technology (300829.SZ) announced that its stock price saw cumulative closing price gains exceeding 30% over three consecutive trading days on September 17, 18, and 21, 2026, triggering the criteria for abnormal stock trading fluctuations.
The company stated that its current main business remains the production and sale of lactic acid and related product lines. Its annual 75,000-ton polylactic acid (PLA) biodegradable new materials project is still in the trial operation phase. The timeline for project commissioning and capacity release remains uncertain, and the company has not yet received any orders related to PLA.
Jindan Technology urged investors to make rational investment decisions and be mindful of investment risks.
Source
财联社Eastern
Part of this Story
Jindan Technology stock surges 30% in three days; firm says no PLA orders received